NCT07801365 Combined Popliteal and Adductor Canal Blocks for Postoperative Analgesia in Children With Cerebral Palsy
| NCT ID | NCT07801365 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Diskapi Yildirim Beyazit Education and Research Hospital |
| Condition | Cerebral Palsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-09-27 |
| Primary Completion | 2027-09-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-09-27 with a primary completion date of 2027-09-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective, randomized, controlled trial aims to evaluate the postoperative analgesic efficacy of combined ultrasound-guided popliteal sciatic nerve block and adductor canal block in children with cerebral palsy undergoing elective lower extremity surgery. Children aged 3-18 years with American Society of Anesthesiologists (ASA) physical status II-III will be randomized into two groups. Participants in the intervention group will receive combined popliteal sciatic nerve block and adductor canal block in addition to general anesthesia, whereas participants in the control group will receive general anesthesia with intravenous analgesia without peripheral nerve block. Postoperative pain will be assessed using the revised Face, Legs, Activity, Cry, Consolability (r-FLACC) scale at 1, 2, 6, 12, and 24 hours after surgery by an anesthesiologist blinded to group allocation.
Eligibility Criteria
Inclusion Criteria: * Pediatric patients aged 3-18 years * Diagnosis of cerebral palsy * Scheduled to undergo lower extremity surgery * American Society of Anesthesiologists (ASA) physical status II-III * Scheduled for elective surgery * Written informed consent obtained from a parent or legal guardian Exclusion Criteria: * Age younger than 3 years or older than 18 years * Coagulopathy or any contraindication to peripheral nerve block * Known allergy to local anesthetics * Infection at the planned block site
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07801365 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 18 Years, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07801365 currently recruiting?
Yes, NCT07801365 is actively recruiting participants. Contact the research team at elifsule-91@hotmail.com for enrollment information.
Where is the NCT07801365 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07801365 clinical trial?
NCT07801365 is sponsored by Diskapi Yildirim Beyazit Education and Research Hospital. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.